Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Items stated in the management plan
Annual updateNet SalesNot disclosed → More than ¥3.3 trillion
Operating profitNot disclosed → More than ¥330 billion (business profit)
Operating profit marginNot disclosed → More than 10% (business profit margin)
Only the target level is shown because the current level for comparison was not provided.Total investment planApproximately ¥100 billion (commercial ship business, 2026–2035)
Investment amount by sectorField Investment amount eligible for the Shipbuilding Industry Revitalization Fund / Amount ¥45 billion, Field Other investment amount / Amount ¥55 billion
Key initiatives
01Physical AI integration across various products
02Commercial ship DX initiatives
03Expansion of construction capacity
04Moving Away from a Labor-Intensive Business Model
05Automation and robotics
06Digital shipyard transformation
07Entire shipyard: digital twinning and optimisation
08Provide one-stop healthcare solutions
09Provide support to extend the period people can remain at home as much as possible
Segment targetSegment Sakaide Plant (commercial ship business) / Revenue More than ¥200 billion / Profit Business profit margin of 15% (target)
Non-financial targetsIndicator Track record of implementing in-hospital operations services / Target value 80 hospitals (expected in 2027) / Timing 2027, Indicator Track record of implementing nursing care and medical services / Target value 30 nursing care facilities / 12 hospitals (expected) / Timing Not disclosed, Indicator Cumulative number of hinotori surgeries / Target value More than 22,000 / Timing End of September 2026
Size of the Target MarketApproximately ¥1 trillion per year (estimated cost savings from extending the period people remain at home through Home LEO, calculated by the company based on various reports)
Risks identified by the company
The labor-intensive nature of the shipbuilding industry
Decline in the number of skilled welders
Difficulty automating shipbuilding operations due to complex worksite environments and tacit knowledge
Shortage of medical and nursing care workers
Insufficient hospital beds and strained capacity at nursing care facilities
Difficulties related to safety, health and financial management in older people’s lives at home
Reason for revision or withdrawal
Make reliable and agile investments ahead of other companies using equity-like financing, and achieve revenue of more than ¥3.3 trillion and business profit of more than ¥330 billion, with a business profit margin of more than 10%, in FY2030
| Item | Details |
|---|---|
| Plan name | Group Vision 2030 |
| Plan period | Toward FY2030 (start year not stated) |
| Progress against the plan | Annual update |
| Sales Target | Not disclosed → More than ¥3.3 trillion |
| Operating profit target | Not disclosed → More than ¥330 billion (business profit) |
| Operating profit margin target | Not disclosed → More than 10% (business profit margin) |
| Total investment plan | Approximately ¥100 billion (commercial ship business, 2026–2035) |
| Investment amount by sector | Field Investment amount eligible for the Shipbuilding Industry Revitalization Fund / Amount ¥45 billion, Field Other investment amount / Amount ¥55 billion |
| Segment target | Segment Sakaide Plant (commercial ship business) / Revenue More than ¥200 billion / Profit Business profit margin of 15% (target) |
| Non-financial targets | Indicator Track record of implementing in-hospital operations services / Target value 80 hospitals (expected in 2027) / Timing 2027, Indicator Track record of implementing nursing care and medical services / Target value 30 nursing care facilities / 12 hospitals (expected) / Timing Not disclosed, Indicator Cumulative number of hinotori surgeries / Target value More than 22,000 / Timing End of September 2026 |
| Key initiatives | Physical AI integration across various products, Commercial ship DX initiatives, Expansion of construction capacity, Moving Away from a Labor-Intensive Business Model, Automation and robotics, Digital shipyard transformation, Entire shipyard: digital twinning and optimisation, Provide one-stop healthcare solutions, Provide support to extend the period people can remain at home as much as possible |
| Reason for revision or withdrawal | Make reliable and agile investments ahead of other companies using equity-like financing, and achieve revenue of more than ¥3.3 trillion and business profit of more than ¥330 billion, with a business profit margin of more than 10%, in FY2030 |
| Size of the Target Market | Approximately ¥1 trillion per year (estimated cost savings from extending the period people remain at home through Home LEO, calculated by the company based on various reports) |
| Risks identified | The labor-intensive nature of the shipbuilding industry, Decline in the number of skilled welders, Difficulty automating shipbuilding operations due to complex worksite environments and tacit knowledge, Shortage of medical and nursing care workers, Insufficient hospital beds and strained capacity at nursing care facilities, Difficulties related to safety, health and financial management in older people’s lives at home |
Items this document does not state (11)
Net income targetROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share pricePlan assumptionsResults under the previous planDate of board resolutionPublication date
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To use equity-like financing to make reliable and agile investments ahead of other companies. In shipbuilding, this includes expanding construction capacity and improving productivity, while in healthcare, the company will advance the provision of solutions connecting medical care, nursing care and home care.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.